| Biography | |
|---|---|
 Dr. Takuma Hayashi National Hospital Organization Kyoto Medical Center, Japan |
|
| Title: Relationship between Cancer metastasis and Stem Cell: including Severity of COVID-19 | |
| Biography: Dr. Hayashi is professor at Shinshu University Graduate School of Medicine since 2002, and also Section Head, National Hospital Organization Kyoto Medical Center, Japan. He received his Ph.D. from Inst. for Medical Science, University of Tokyo in 1994. He was research training as a resident staff in Virology Division, at National Cancer Center, Tokyo Japan for 3 years until 1994 and joined Whitehead Institute for Biomedical Research (WI)/Mass.Inst.Tech.(M.I.T.) that year. He did postdoctoral training in the laboratory of Dr. Rick A. Young (Membership in the National Academy of Sciences, WI/M.I.T.), and also was a research member of USA Project of AIDS vaccine development (Project Leader: Dr. David Baltimore, Nobel Laureate, Cal.Tech.). After postdoctoral training, he got faculty position Lecture, Mass. General Hospital (MGH)/Harvard Medical School (HMS) in 1997. He has been studying the antigen presentation system by MHC class I with LMP2-deficient mice, under the cooperation of Dr. Susumu Tonegawa (Nobel Laureate, M.I.T.). He identifies diagnostic biomarkers, LMP2, Cyclin B1 and Cyclin E, for malignant tumor, i.e. uterine leiomyosarcoma, and BRCA1 and S100A4 for ovarian carcinoma. Current research focus: molecular approach of tumorigenesis of uterine leiomyosarcoma and ovarian cancer. | |
